Skip to main content
Clinical Trials/NCT02295735
NCT02295735
Completed
Not Applicable

A Randomized Controlled Parallel-group Trial to Investigate the Effectiveness of Two Silicone Dressings for Sacral and Heel Pressure Ulcer Prevention Compared to no Dressings

PD Dr. Jan Kottner1 site in 1 country475 target enrollmentJune 2015
ConditionsPressure Ulcer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pressure Ulcer
Sponsor
PD Dr. Jan Kottner
Enrollment
475
Locations
1
Primary Endpoint
Number of Pressure Ulcers Category II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Proportion)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this randomized controlled trial is to test the efficacy of preventive dressings for pressure ulcer prevention.

Detailed Description

Patients of intensive acute care and residents of institutional long-term care facilities are at high risk for developing pressure ulcers (PUs). PU standard prevention includes repositioning, early mobilization and the use of special support surfaces. The use of prophylactic dressings might reduce friction and shear forces and/or modify the microclimate of the skin and might therefore protect the skin and underlying tissues from pressure/deformation injury. The primary objective of this study is to determine if preventive silicone dressings (Mepilex® border) applied to the heels and to the sacrum in addition to PU standard prevention reduces PU incidence category II, III, IV, and deep tissue injury compared to PU standard alone in at risk hospital patients.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
July 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
PD Dr. Jan Kottner
Responsible Party
Sponsor Investigator
Principal Investigator

PD Dr. Jan Kottner

PD Dr. rer cur

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of Pressure Ulcers Category II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Proportion)

Time Frame: Duration of hospital stay, an average of 12.6 (SD +/-12.7) days

The primary outcome was the cumulative incidence of Pressure ulcer category II, III, IV, unstageable and DTI at heels or sacrum. Pressure ulcers were categorized according to the NPUAP/EPUAP 2014 classification System. The occurrence of a new pressure ulcer of any category was assessed and documented daily during the study period. The Categories are defined as follows: Category I (nonblanchable erythema); Category II (Partial thickness Skin loss); Category III (Full Thickness Skin loss); Category IV (Full Thickness tissue loss); Unstageable (Depth unknown); Deep tissue injury (suspected Deep tissue injury, Depth unknown)

Secondary Outcomes

  • Number of Preventive Sacrum Dressings Used for Pressure Ulcer Prevention(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Time to Pressure Ulcer Development of Pressure Ulcers Category II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Event Free Survival Time of Pressure Ulcers Category II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Days, Kaplan Meier Analysis)(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Density Rate of Pressure Ulcers Category II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Proportion Per 1000 Bed Days, Rate)(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Number of Pressure Ulcer Category I (Non-blanchable Erythema) II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Proportion)(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Numbers of Support Surface Used for Pressure Ulcer Prevention (Total)(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Number of Preventive Heel Dressings Used for Pressure Ulcer Prevention(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Number of Pressure Ulcers Category I (Non-blanchable Erythema) II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Proportion Per 1000 Bed Days, Rate)(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Time to Pressure Ulcer Development of Pressure Ulcers Category I, II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Event Free Survival Time of Pressure Ulcers Category I, II, III, IV, Unstageable, Deep Tissue Injury (DTI) at Heels and/or Sacrum (Days, Kaplan Meier Analysis)(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)
  • Follow up Period of Included ICU Patients (Days)(Duration of hospital stay, an average of 12.6 (SD +/-12.7) days)

Study Sites (1)

Loading locations...

Similar Trials